Encycle Therapeutics Inc.
Records under this name other than patents Encycle Therapeutics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Encycle Therapeutics Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,072,616 | Cyclic peptides targeting alpha-4-beta-7 integrin Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,713,338 | Cyclic peptides multimers targeting α-4-β-7 integrin Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,077,611 | Cyclic peptides multimers targeting α4β7 integrin Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,111,273 | Cyclic peptides multimers targeting alpha-4-beta-7 integrin Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,286,281 | Homodetic cyclic peptides targeting alpha-4-beta-7 integrin Formerly held Lapsed on the fee record Ended Mar 29, 2026 · From the USPTO record | Lapsed on the fee record | Ended Mar 29, 2026 | From the USPTO record |
| US 11,046,695 | Fragment synthesis of substituted cyclic peptides Formerly held Lapsed on the fee record Ended Jun 29, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 29, 2025 | From the USPTO record |
| US 10,981,921 | Fragment synthesis of substituted cyclic peptides Formerly held Lapsed on the fee record Ended Apr 20, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 20, 2025 | From the USPTO record |